baber/WOPTO huggingface dataset:
Patent AT-E374458-T1 (AT)
Inventor: DE LAMEILLEURE JAN
IPC: G06T9/00
Filed: 1999-05-21
Granted: 2007-10-15
Abstract: A method is described for compressing and/or transporting and/or decompressing a digital signal. The most significant bits of a sample of the digital signal are compressed and transported as a compressed transport sample. Methods are used to improve the compression and transport as hybrid DPCM and a dynamic shift of clip range of prediction errors. For every sample, not only a compressed transport sample but also a residual transport sample is transmitted. The residual transport sample is either equal to the least significant bits of the sample or equal to a substitution value which is a function of the clipping error from the compression of the most significant bits of the said sample. Apparatuses are described for compression and/or transport and/or decompression of a digitised television IF signal according to the method. <IMAGE>
Patent AT-E204158-T1 (AT)
Inventor: ZASTROW LEONHARD
IPC: A61K8/00
Filed: 1999-01-28
Granted: 2001-09-15
Abstract: The invention relates to a marine-based cosmetic product provided for regenerating and stimulating skin cells. The product is comprised of 0.01 to 50 wt. %, with regard to the total mass, of an active ingredient combination made of a) a product of an enzymatic extraction process of sea plankton Artemia salina, whereby the extraction product is comprised of phosphorylated nucleotides with the main components diguanosine-tetraphosphate; b) D-myo-inosite-1,4,5-triphosphate; c) glucan; whereby the ratio a:b:c is in the area of 1:0.1-50:0.1-30; and of a content of additional cosmetic active ingredients and supporting materials ranging from 99.99 to 50 wt. %. Use of the product results in a synergetic effect against aggressive environmental influences by naturally strengthening the immune system of the skin, stimulating skin regeneration and, at the same time, providing ultraviolet protection with the assistance of improved keratin barriers.
Patent AT-E228018-T1 (AT)
Inventor: MARTI ALEXANDRE
IPC: A61K41/00
Filed: 1999-04-22
Granted: 2002-12-15
Abstract: The invention concerns a 5-aminolevulinic acid ester (E-ALA) solution for producing a pharmaceutical preparation useful for diagnosing and/or treating tissue and/or cell pathologies by local radiation exposure using radiation emitted by a light source energy followed, in the case diagnosis, by detection of fluorescent protoporphyrin IX (Pp1X). The E-ALA concentration in the solution is less than 1% and ranges between 0.01% and 0.5%. The low E-ALA concentration in the solution increases Pp1X synthesis and homogenises its distribution in the cell layers while highly reducing the secondary toxicity for the treated cells.
Patent AT-E463115-T1 (AT)
Inventor: HENDERSON ALEX
IPC: H04L12/56
Filed: 1999-08-02
Granted: 2010-04-15
Abstract: A system for filtering data comprises a filtering database for storing layered rule tables and a data filtering engine coupled to the filtering database for filtering the input data using the layered rule tables. The data filtering engine filters or classifies input data using tests or rules performed on the data elements in the input data. The data elements are segments of data in the input data and are selected from the input data using a data element locator. Preferably, each rule table in the filtering database comprises a data element locator, a default rule, and zero or more filtering rules. The filtering rules comprise the tests or rules that are to be applied to the data elements. Each rule table corresponds to a single data element and each filtering rule in the rule table is to be applied to that data element.
Patent AT-E262762-T1 (AT)
Inventor: WESTON MARTIN
IPC: H04N5/14
Filed: 1999-11-03
Granted: 2004-04-15
Abstract: Motion between adjacent fields of an interlaced video signal is analyzed by vertically interpolating the current field to produce a line signal which corresponds in vertical position with lines from the succeeding and preceding fields; and subtracting the signals to provide a field difference. The effect of vertical detail is reduced by comparing two field differences or by subtracting a local or global detail signal from the field difference.
Patent AT-E234726-T1 (AT)
Inventor: FITZGERALD FERGUS RUPERT
IPC: B32B27/12
Filed: 1999-11-30
Granted: 2003-04-15
Abstract: An underground storage tank is lined in situ by first clearing the inner surface of the tank using water jetting. The surface is then inspected and grit blasted. A corrosion barrier coating in the form of glass flakeepoxy resin is applied to a minimum dry film thickness of 1000 microns. An adhesive is applied to the barrier coating and sheets of an HDPE interstitial grid are bonded to the adhesive forming an air gap of about 5 mm. A pliable glass reinforced plastic layer is laid upon the grid. The GRP material is exposed to UV lamps to form an impermeable shell within the tank. A surface coating layer may be applied. A leak detector is installed in the interstitial space defined by the grid.
Patent AT-E229049-T1 (AT)
Inventor: DEHNICKE STEFAN
IPC: C08G73/00
Filed: 1999-12-10
Granted: 2002-12-15
Abstract: The invention relates to a method for producing poly(1,4-phenylenazine-N,N-dioxide) and derivatives thereof which are substituted in the ring, by oxidizing p-benzoquinonedioxime or the corresponding derivative thereof which is substituted in the ring, using polyanions of the halogens bromine or iodine. Tribromide Br3- or triiodide I3- can be used as polyanions and these can be obtained in situ from H2O2 and a bromide or iodide.
Patent AT-E227559-T1 (AT)
Inventor: KILIAN HENRYKA
IPC: A61K8/18
Filed: 1999-06-22
Granted: 2002-11-15
Abstract: The preparation consists of 0.05-5% by weight of nutritive substances, 0-20% by weight of fatty substances, 0.5-15% by weight of alcohol, 0-1.5% by weight of fragrance compound, 0.5-5% by weight of moisturizing substance, 0-20% by weight of emolient, 0.1-20% by weight of surface-active substances, 0.02-1.0% by weight of preserving agent, 0-5% by weight of conditioning agent, 0.1-25% by weight of flax glycerol-glycol-water biocomplex, 0-2.5% by weight of viscosity regulator and pH regulator depending upon the need.
Patent AT-E245570-T1 (AT)
Inventor: FRANZEN BJOERN
IPC: B65D1/20
Filed: 1999-11-05
Granted: 2003-08-15
Abstract: A container has a chamber (10) for liquid, a pouring opening (30) in the upper part of the chamber and having an essentially vertical longitudinal axis, and a handle (20) arranged above the chamber. In the handle there is an air duct (22), which at a first end emerges in the chamber and at a second end emerges in the pouring opening. In the pouring opening, a wall (34) is placed between a part (36) for liquid which is connected to the chamber and a part (38) for air in which the second end of the air duct emerges. An opening (40) is arranged in the wall between the part for liquid and the part for air. This opening ensures better manufacturing quality and ventilation when the container is emptied.
Patent DE-204607-T1 (DE)
IPC: B29C53/66
Filed: 1986-05-22
Abstract: Apparatus whereby a filament web impregnated with resin in the unpolymerized state is fed to a pole (1) at a predetermined angle ( alpha ) with respect to a plane perpendicular to this latter. The pole (1) is drawn in rotation about its axis (X-X') and the filament web is displaced along the pole from the bottom end to the top end thereof in a direction parallel to the axis of the pole while this latter is being driven in rotation. A plurality of parallel fiber slivers (8, 9, 10) spaced a distance apart are fed simultaneously to the pole (1) in a plurality of layers. The spacing between the slivers is progressively increased during displacement of the slivers between the bottom end and the top end of the pole and progressively decreased in the opposite direction. Similarly, the angle of the slivers to a plane perpendicular to that axis is progressively increased and decreased in the same directions that the spacing is increased and decreased. The apparatus is useful for forming a reinforcement wound structure of filaments on a cylindrical pole (1) of plastic material, the wound structure of filaments having a density which progressively decreases from the bottom end to the top end of the pole in each layer.
Patent DE-240422-T1 (DE)
IPC: C12P13/00
Filed: 1987-03-27
Abstract: Process of purification of carnitine, in which the aqueous medium containing the carnitine is first acidified, in order to cause the proteins present to precipitate, and, after their separation, the water of the medium is replaced by a lower alcohol which dissolves carnitine, at least hot, while the mineral substances separate out.
Patent DE-646937-T1 (DE)
Inventor: SAGAWA MASATO
IPC: B22F3/12
Filed: 1991-11-28
Abstract: In the die-pressing method of the magnet powder and fine powder, the powder is filled at a high density in a rubber mold (10), is occasionally preliminarily magnetized (4a) in the rubber mold and is then compacted under magnetic field or without magnetic field. Cracking of the magnet green compact is prevented. A sintered compact having density of 90% or more can be produced using the fine powder. <IMAGE>
Patent ES-2068800-T1 (ES)
Inventor: GERGELY GERHARD
IPC: A61K47/38
Filed: 1993-01-12
Abstract: PCT No. PCT/EP93/00055 Sec. 371 Date Jul. 13, 1994 Sec. 102(e) Date Jul. 13, 1994 PCT Filed Jan. 12, 1993 PCT Pub. No. WO93/13760 PCT Pub. Date Jul. 22, 1993The pharmaceutical formulation in the form of an effervescent and/or disintegrating tablet or of instant granules contains at least one active ingredient having an irritating taste and at least one matrix which delays the release of the active ingredient and is present as an intimate mixture with the active ingredient particles or covers said particles and is applied to a carrier. The formulation releases at most 65%, preferably at most 50%, of the active ingredient in aqueous solution at room temperature within about 2 min but more than 70%, preferably at least 80%, of the active ingredient within max. 20 min, preferably max. 15 min, in 0.1N HCl at 38 DEG  C. The matrix preferably contains at least one fatty ester and/or one wax, preferably having a melting point between 30 DEG  and 45 DEG  C., in particular between 32 DEG  and 35 DEG  C., and/or at least one cellulose derivative and/or at least one polymethacrylate. In particular, the active ingredient is present in an amount of less than 60 mg, preferably less than 10 mg, and the matrix is present in an amount of 1 to 10, preferably 3 to 5, times the amount of active ingredient per tablet or granule dose. For the treatment of diarrhoea by means of loperamide, the matrix additionally contains a mixture which serves to compensate for the electrolyte loss in the body and an amount of alkali metal and/or alkaline earth metal salts, preferably of organic salts, and of chlorides.
Patent CY-1109754-T1 (CY)
Inventor: BLASCHKE ULRICH KURT
IPC: C07K14/535
Filed: 2010-01-27
Abstract: Method for recovering biologically active human granulocyte colony-stimulating factor (G-CSF) from inclusion bodies (IB) by: (a) solubilizing IB in a buffer that contains a denaturing agent (I) and reduced glutathione; (b) refolding by diluting the solubilizate with a buffer containing both oxidized and reduced glutathione; and (c) purifying refolded G-CSF by at least one chromatography step. ACTIVITY : Immunostimulant; Cytostatic. No details of tests for these activities are given. MECHANISM OF ACTION : Stimulating proliferation and differentiation of hematopoietic precursor cells.
Patent CY-1114769-T1 (CY)
Title: Διασπαρσιμα στο νερο αγροχημικα σκευασματα που αποτελουνται απο πολυαλκοξυτριγλυκεριδια ως υποκινητες διεισδυσης
Inventor: VERMEER RONALD
IPC: A01N51/00
Filed: 2014-01-17
Abstract: Η εφεύρεση αφορά νέα αγροχημικά σκευάσματα που μπορούν να διασπαρούν στο νερό, για παράδειγμα συμπυκνώματα εναιωρήματος με βάση νερό και διασπάρσιμα στο νερό κοκκία αγροχημικών δραστικών συστατικών που περιέχουν έναν ενισχυτή διείσδυσης από την κατηγορία των πολυαλκοξυτριγλυκεριδίων. Η εφεύρεση αφορά επίσης μια μέθοδο για την παραγωγή των εν λόγω σκευασμάτων και τη χρήση αυτών για την εφαρμογή των δραστικών συστατικών που περιέχονται σε αυτά.
Patent CY-1115213-T1 (CY)
Title: Διαταξη αερολυσης
Inventor: FINK JAMES B
IPC: A61M15/00
Filed: 2014-03-17
Abstract: Μία διάταξη μεταφοράς αερολύματος για γεννήτριες ιατρικού αερολύματος περιλαμβάνει ένα σώμα, ρευστά συζευγμένο με έναν εκνεφωτή και σε μία διεπαφή με έναν ασθενή. Μία πρόσληψη ατμοσφαιρικού αέρα διαμορφώνεται μέσα σε ένα χαμηλότερο σώμα. Το σώμα είναι σχηματισμένο και διαμορφωμένο, ώστε να βελτιστοποιεί την ανάμειξη του ατμοσφαιρικού αέρα από την πρόσληψη του ατμοσφαιρικού αέρα και το αερόλυμα, το οποίο παράγεται από τον εκνεφωτή, καταλήγοντας στην διαμόρφωση ενός νέφους αερολύματος που έχει τα βέλτιστα χαρακτηριστικά για την χορήγηση του αερολύματος στο πνευμονικό σύστημα του ασθενούς, όπως είναι οι περιοχές του κεντρικού ή του βαθέος πνεύμονα. Το σχήμα και οι διαστάσεις του σώματος είναι περαιτέρω σχεδιασμένες, ώστε να ελαχιστοποιούν την εναπόθεση του αερολύματος, βελτιώνοντας έτσι την αποτελεσματικότητα της χορήγησης.
Patent CY-1115495-T1 (CY)
Title: Μακρας δρασης πολυπεπτιδια και μεθοδοι παραγωγης και χορηγησης αυτων
Inventor: FARES FUAD
IPC: C07K14/505
Filed: 2014-08-25
Abstract: Αποκαλύπτονται ένα πολυπεπτίδιο και πολυνουκλεοτίδιο που κωδικοποιούν αυτά τα οποία περιλαμβάνουν δυο τουλάχιστον αλληλουχίες καρβοξύ-τελικού πεπτιδίου (Carboxy-Terminal Peptide- CΤΡ) χοριακής γοναδοτροπίνης προσδεμένες σε ένα γονίδιο που μας ενδιαφέρει. Αποκαλύπτονται επίσης φαρμακευτικές συνθέσεις που περιλαμβάνουν το πολυπεπτίδιο και πολυνουκλεοτίδια της εφεύρεσης και μέθοδοι για τη χρήση αυτών.
Patent CY-1117402-T1 (CY)
Title: Ινδανυλ-υποκατεστημενες 4,5,6,7-τετραϋδρο-1η-πυραζολο[4,3-c]πυριδινες, η χρηση αυτων ως φαρμακο, και φαρμακευτικα παρασκευασματα που τις περιεχουν
Inventor: BIALY LAURENT
IPC: C07D471/04
Filed: 2016-01-28
Abstract: Η εφεύρεση αφορά υποκατεστημένες 4,5,6,7-τετραϋδρο-1 Η-πυραζολο[4,3-c] πυριδίνες του τύπου (I), τη χρήση αυτών ως φάρμακο καν φαρμακευτικά παρασκευάσματα που τις περιέχουν. Οι ενώσεις του τύπου (I) επενεργούν στον δίαυλο καλίου TASK-1. Οι ενώσεις είναι ιδιαιτέρως κατάλληλες για τη θεραπευτική αγωγή ή πρόληψη κολπικών αρρυθμιών, για παράδειγμα κολπικής μαρμαρυγής (AF) ή κολπικού πτερυγισμού.
Patent CY-1120311-T1 (CY)
Title: Διαταξη κυκλωματος για την παραγωγη τασης δοκιμων, ιδιαιτερα για τη δοκιμη της μονωσης εγκατεστημενων καλωδιων ισχυος
Inventor: REKERS PHILIPP
IPC: G01R31/14
Filed: 2018-06-05
Abstract: Η εφεύρεση αναφέρεται σε διάταξη κυκλώματος για την παραγωγή τάσης δοκιμών, ιδιαίτερα για τη δοκιμή ηλεκτρικού υλικού, η οποία περιλαμβάνει πηγή εναλλασσόμενης τάσης ή πηγή τάσης με σταθερή ή σχεδόν σταθερή τάση και κύκλωμα συνδεόμενο με την πηγή τάσης για την παραγωγή κατά προτίμηση εναλλασσόμενης τάσης U0 μικρής συχνότητας. Με την πηγή εναλλασσόμενης τάσης συνδέεται κατά προτίμηση αναστροφέας που υλοποιείται σαν δίκτυο συντονισμού. Ένας μετασχηματιστής που συνδέεται με τον αναστροφέα χρησιμεύει για την παραγωγή υψηλής τάσης UT και ιδιαίτερα σειριακή και/ή συνδεσμολογία πολλαπλών βαθμίδων ανορθωτή για τη μετατροπή της υψηλής τάσης σε συνεχή τάση UHV μεταβλητού πλάτους. Επί πλέον προβλέπεται κύκλωμα για τη φόρτιση του δοκιμίου με τη συνεχή τάση UHV και για την αποφόρτιση του δοκιμίου. Στο αναφερθέν κύκλωμα η είσοδος του αναστροφέα συνδέεται με την εναλλασσόμενη πηγή τάσης U0 και η έξοδος του αναστροφέα συνδέεται με το κύκλωμα για την φόρτιση και αποφόρτιση του δοκιμίου. Στην πλευρά εισόδου ο αναστροφέας διαμορφώνεται με (n) στοιχεία και στην πλευρά εξόδου περιέχει πολλαπλές (k) βαθμίδες. Η συνδεσμολογία ανορθωτή (C1 έως C4, S5 έως S8) υλοποιείται σαν συνδεσμολογία αναστροφέα για τη συνδυασμένη αποφόρτιση του δοκιμίου (15), οι διακόπτες της οποίας μπορούν να συνδέονται σαν βαλβίδες που καθιστούν δυνατή τη ροή του ρεύματος μόνο κατά τη μια κατεύθυνση.
Patent CY-1122841-T1 (CY)
Title: Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων
Inventor: LIN KOCHUNG
IPC: A61K38/31
Filed: 2020-02-06
Abstract: Η εφεύρεση αφορά νέες ενώσεις πολυαλκυλενογλυκόλης και μεθόδους χρήσης αυτών. Συγκεκριμένα, ενώσεις οι οποίες περιλαμβάνουν ένα νέο σύζευγμα πολυαιθυλενογλυκόλης χρησιμοποιούνται μόνες ή σε συνδυασμό με αντιιικους παράγοντες για την αγωγή μίας ιικής μόλυνσης όπως η χρόνια ηπατίτιδα C.
Patent CY-1125180-T1 (CY)
Title: Συστημα αστερισμου δορυφορων χαμηλης γηϊνης τροχιας για επικοινωνιες με επαναχρησιμοποιηση φασματος γεωστατικων δορυφορων
Inventor: OLSON ERLEND
IPC: H04B7/185
Filed: 2022-01-05
Abstract: Ένα σύστημα για την επαναχρησιμοποίηση φάσματος επικοινωνιών που έχει καταμεριστεί στην GEO σε έναν σύστημα επικοινωνιών που βασίζεται στον αστερισμό δορυφόρων LEO, έτσι ώστε τα σήματα που προέρχονται από δορυφόρο LEO να μην εμφανίζονται στο εύρος δέσμης κεραιών επίγειου σταθμού που σκοπεύουν προς την GEO, και οι δορυφόροι να διαμορφώνονται έτσι ώστε να παρέχουν επικοινωνίες μέσω διαχείρισης των αντίστοιχων εκπομπών δέσμης αυτών, που μπορεί να περιλαμβάνουν μια δέσμη προς τα εμπρός και μια δέσμη προς τα πίσω, των οποίων οι γωνίες ελέγχονται έτσι ώστε να προβάλλουν τη δέσμη και να μειώνουν ή να εξαλείφουν τη δυνατότητα για παρεμβολή με κεραίες επίγειου σταθμού που σκοπεύουν προς την GEO. To σύστημα και οι δορυφόροι LEO μπορεί να παρέχουν ουσιαστικά 100% κάλυψη ενός επίγειου σταθμού που βρίσκεται οπουδήποτε στην επιφάνεια της Γης, χωρίς συντονισμό με τους δορυφόρους GEO ή σταθμούς εδάφους που σκοπεύουν προς την GEO. To σύστημα μπορεί επίσης να παρέχει επίγειους σταθμούς οι οποίοι είναι διαμορφωμένοι έτσι ώστε να ενισχύουν την απομόνωση μεταξύ του συστήματος επικοινωνιών GEO και του συστήματος επικοινωνιών LEO χρησιμοποιώντας το ίδιο φάσμα για τη μείωση της δυνατότητας εντοπισμού της επικοινωνίας LEO από τις κεραίες επίγειου σταθμού που σκοπεύουν προς την GEO.
Patent HR-P20100426-T1 (HR)
Inventor: BOCCARDI MASSIMO
IPC: B67B3/28
Filed: 2010-08-02
Abstract: Pritezno/okretna glava (1) za pritezanje i brtvljenje prethodno namotane kapice (5) na navojni vrat (6) spremnika (7), gdje glava (1) obuhvaća: -	tijelo (2) koje se proteže uzduž specificirane uzdužne osi (X-X) i koja se može spojiti na uređaj za zaštićivanje kapicom (3) tako da se može okretati oko spomenute osi (X-X) i može se pomicati aksijalno između pozicije sustezanja i radne pozicije napredovanja; -	dio (4) za pritiskanje kapice koji je sposoban zahvatiti spomenutu kapicu (5) kako bi je pritegnuo na spomenuti navojni vrat (6); pri čemu se spomenuti dio za pritiskanje kapice (4) proteže uzduž spomenute uzdužne osi (X-X) da oblikuje proširenje spomenutog tijela (2) i udružen je u djelovanju sa spomenutim tijelom (2) preko spojnih sredstava (12, 13) koja sadrže pozitivnu spojku između vodilice (12), smještene ili u spomenutom tijelu (2) ili u spomenutom dijelu (4) za pritiskanje kapice, zatim sadrže klin (13) koji je, za vrijeme pomicanja spomenutog dijela (4) od proširene konfiguracije do stisnute konfiguracije, čvrsto spojen na drugoga od spomenutog tijela (2) i spomenutog dijela (4) za pritiskanje kapice, tako da je spomenuti dio za pritiskanje kapice pomičan u odnosu na spomenuto tijelo (2) između spomenute pozicije sustezanja koja definira spomenutu stisnutu konfiguraciju a spomenuta radna pozicija napredovanja definira spomenutu proširenu konfiguraciju, pri čemu su spomenuta spojna sredstva (12, 13) sposobna ograničavati spomenuti relativni pomak na okretno-prijenosni pomak koji ima samo jedan stupanj slobode, tako da to olakšava zavrtanje spomenute kapice (5) na spomenuti spremnik (7) za vrijeme pomicanja spomenutog dijela (4) od spomenute proširene konfiguracije do spomenute stisnute konfiguracije, naznačena time, da glava (1) nadalje obuhvaća: - asimetrična spojna sredstva (18) koja sadrže prednji zupčanik s asimetričnim zupcima (20) čiji profil omogućava da spomenuti klin (13) dopire od spomenutog zupčanika za vrijeme pomicanja spomenutog dijela (4) od spomenute proširene konfiguracije do spomenute stisnute konfiguracije, te dozvoljava zupcima (20) da budu prekoračeni klinom (13) kada predodređena sila obrtanja bude premašena za vrijeme suprotnog pomaka, a spomenuta asimetrična spojna sredstva budu umetnuta između spomenutog dijela (4) za pritiskanje kapice i spomenutog tijela (2) i budu sposobna iz spomenutog tijela (2) na spomenuti dio (4) za pritiskanje kapice prenijeti silu zavrtanja za pritezanje spomenute prethodno namotane kapice (5) na spomenuti spremnik (7) za vrijeme pomicanja spomenutog dijela (4) od spomenute proširene konfiguracije do spomenute stisnute konfiguracije, te da ostave spomenuti dio (4) za pritiskanje kapice uglavnom slobodnim za okretanje u odnosu na spomenuto tijelo (2) prilikom pomicanja spomenutog dijela (4) za pritiskanje kapice od spomenute stisnute konfiguracije do spomenute proširene konfiguracije. Patent sadrži još 7 patentnih zahtjeva.
Patent SI-1585770-T1 (SI)
Title: Recognition molecules for the treatment and detection of tumours
Inventor: GOLETZ STEFFEN
IPC: A01K67/00
Filed: 2004-01-23
Abstract: Recognition molecules (I) comprising sequences that bind specifically to the glycosylated MUC1 tumor epitope, are new. New recognition molecules (I) comprise: (a) sequences (1) or (2); (b) sequences (3) or (4) and (c) sequences (5) and (6), and bind specifically to the glycosylated MUC1 tumor epitope. Asp-Ala-Trp-Met-Asp (1) Asn-Tyr-Trp-Met-Asn (2) Glu-Ile-Arg-Ser-Lys-Ala-Asn-Asn-His-Ala-Thr-Tyr-Tyr-Ala-Glu-Ser-Val-Lys-Gly (3) Glu-Ile-Arg-Leu-Lys-Ser-Asn-Asn-Tyr-Thr-Thr-His-Tyr-Ala-Glu-Ser-Val-Lys-Gly (4) Gly-Gly-Tyr-Gly-Phe-Asp-Tyr (5) His-Tyr-Tyr-Phe-Asp-Tyr (6) Independent claims are also included for the following: (1) construct (II) comprising (I) fused, chemically coupled or non-covalently associated with additional sequences and/or structures; (2) isolated nucleic acid (III) that encodes (I) or (II); (3) expression cassette or vector that contains (III), operatively linked to a promoter; (4) virus or host cell comprising at least one cassette or vector of (3); (5) organism containing at least one host cell of (4); (6) method for preparing (I) and (II); and (7) kit containing (I) and/or (II). ACTIVITY : Cytostatic. No details of tests for cytostatic activity are given. MECHANISM OF ACTION : Specific binding to the MUC1 epitope; Gene therapy.
Patent SI-1831277-T1 (SI)
Title: Method for producing reactive polyurethane compositions
Inventor: BECKER-WEIMANN KLAUS
IPC: C09J175/00
Filed: 2005-11-28
Abstract: Proposed is a process for preparing a reactive polyurethane composition that is characterized in that in a first process stage, from an isocyanate-reactive polymer or mixture of isocyanate-reactive polymers with a fraction of at least 90%, preferably at least 95%, more preferably at least 99% by weight of linear molecules, by reaction with a polyisocyanate having a molecular weight <500, in a molar deficit of the isocyanate groups of the polyisocyanate relative to the isocyanate-reactive end groups of the polymer or mixture of polymers, a monomer-free thermoplastic polyurethane is prepared which in a second process stage is reacted with a low-monomer-content, isocyanate-terminal prepolymer, in a molar ratio of the isocyanate-reactive end groups of the thermoplastic polyurethane to the isocyanate groups of the prepolymer of 1:1.1 to 1:5, to give the isocyanate-reactive polyurethane composition.